Irinotecan Liposome Combined With Oxaliplatin and Tegafur as Adjuvant Therapy for Pancreatic Cancer

NCT06361316 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

53

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer
Adjuvant Therapy

Interventions

DRUG: Irinotecan liposome injection

Sponsor

Kuirong Jiang

Collaborators

[object Object]